| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/20/2008 | EP1581522B1 Flavaxate derivatives as muscarinic receptor antagonists |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | EP1427417B1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents |
| 02/20/2008 | CN101128458A Tricyclic delta-opioid modulators |
| 02/20/2008 | CN101128457A 凝血酶受体拮抗剂 Thrombin receptor antagonists |
| 02/20/2008 | CN101128436A 甘氨酸衍生物及其用途 Glycine derivatives and their use |
| 02/20/2008 | CN101128434A Amide derivatives |
| 02/20/2008 | CN101125849A 1,4-pyran derivative and use thereof |
| 02/20/2008 | CN100369908C New taxane derivatives |
| 02/20/2008 | CN100369899C Substituted indazoles with anti-cancer activity |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332518 Carboxamides as fungicides in agriculture |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332509 Used for controlling animal pests, in particular arthropods, such as insects and acarids, and helminths |
| 02/19/2008 | US7332501 Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonists |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332495 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332488 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332260 Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing them |
| 02/19/2008 | CA2210072C Crop protection products |
| 02/19/2008 | CA2207100C Pyrimidine derivatives |
| 02/14/2008 | WO2008019292A2 Compositions and methods for potentiating antibiotic activity |
| 02/14/2008 | WO2008018639A2 Glycine transporter inhibitor |
| 02/14/2008 | WO2008017710A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | WO2008017685A1 Nitrate esters of piperidines |
| 02/14/2008 | WO2008017515A1 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 02/14/2008 | WO2008008493A3 Alkyne-substituted pyridone compounds and methods of use |
| 02/14/2008 | WO2008005954A3 Tryphostin-analogs for the treatment of cell proliferative diseases |
| 02/14/2008 | WO2008002245A3 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 02/14/2008 | WO2008002244A3 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 02/14/2008 | WO2007139955A8 Triazole compounds that modulate hsp90 activity |
| 02/14/2008 | WO2007136302A3 Active substances, pharmaceutical composition and a method for the production and use thereof |
| 02/14/2008 | WO2007110704A3 Macrolide compositions as therapeutic agent |
| 02/14/2008 | US20080039640 Process for the preparation of nitrile compounds |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039505 5-((((2R)-1-(4-((S)-1-hydroxyhexyl)phenyl)-4-methyl-5-oxopyrrolidin-2-yl)methoxy)methyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension |
| 02/14/2008 | US20080039502 e.g. N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
| 02/14/2008 | US20080039473 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080038745 Nucleotide analogs with six-membered rings |
| 02/14/2008 | DE102006037724A1 Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices Use of ascorbic acid for the functionalization of matrices |
| 02/14/2008 | CA2660636A1 Nucleosides, drugs containing these and use thereof |
| 02/14/2008 | CA2660538A1 Nitrate esters of piperidines |
| 02/14/2008 | CA2660421A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/13/2008 | EP1887003A1 3-[4-heterocyclyl -1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 02/13/2008 | EP1886996A1 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1885715A1 Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 02/13/2008 | EP1885710A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
| 02/13/2008 | EP1689741B1 Benzoyl amino pyridyl carboxylic acid derivatives as glucokinase activators |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1335908B1 Peroxisome proliferator activated receptor alpha agonists |
| 02/13/2008 | EP1299390B1 Pyrimidine compounds and their use in the preparation of a triazolo -pyrimidine carba nucleoside |
| 02/13/2008 | CN101124220A 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents |
| 02/13/2008 | CN101124212A Chroman derivatives and their use as 5-HT receptor ligands |
| 02/13/2008 | CN101123962A 可诱导一氧化氮合成酶二聚化的抑制剂 Inducible nitric oxide synthase dimerization inhibitor |
| 02/13/2008 | CN101121711A Pyrazolcarbazone derivatives and application thereof |
| 02/13/2008 | CN100368415C 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 02/13/2008 | CN100368404C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/12/2008 | US7329762 Prodrugs of mitotic kinesin inhibitors |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329680 Heterocycle substituted carboxylic acids |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329664 Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 02/12/2008 | US7329318 Methods of crystal precipitation |
| 02/12/2008 | CA2374737C Novel process for synthesis of heteroaryl-substituted urea compounds |
| 02/12/2008 | CA2290992C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 02/12/2008 | CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 02/07/2008 | WO2008016973A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | WO2008016762A1 Fluorogenic protein kinase substrates |
| 02/07/2008 | WO2008016596A2 Pseudobase benzo [c] phenanthridines with improved efficacy, stability, and safety |
| 02/07/2008 | WO2008016184A1 Alpha-carboline derivatives and methods for preparation thereof |
| 02/07/2008 | WO2008015525A2 An improved process for the preparation of alfuzosin hydrochloride |
| 02/07/2008 | WO2008014822A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 02/07/2008 | WO2008014815A1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 02/07/2008 | WO2007144487A3 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses |
| 02/07/2008 | WO2007136300A3 Substituted indoles and a method for the production and use thereof |
| 02/07/2008 | WO2007117778A3 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 02/07/2008 | US20080033175 Process for preparation of 4-amino-3-quinolinecarbonitriles |
| 02/07/2008 | US20080033172 Mutagenic Heterocycles |
| 02/07/2008 | US20080033023 Therapeutic compounds |